Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hsin-Yi Huang, Ming-Chen Wang, Zhi-Yu Chen, Wen-Ying Chiu, Ko-Hua Chen, I-Chan Lin, Wei-Chung Vivian Yang, Chi-Chang Wu & Ching-Li Tseng. (2018) Gelatin–epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief. International Journal of Nanomedicine 13, pages 7251-7273.
Read now
Read now
Edward Meier, Abhijit Narvekar, Ganesh R Iyer, Harvey B DuBiner, Apinya Vutikullird, David Wirta & Kenneth Sall. (2017) Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies. Clinical Ophthalmology 11, pages 669-681.
Read now
Read now
Peter A. Ricketti, Sultan Alandijani, Chen Hsing Lin & Thomas B. Casale. (2017) Investigational new drugs for allergic rhinitis. Expert Opinion on Investigational Drugs 26:3, pages 279-292.
Read now
Read now
DeGaulle I Chigbu & Alissa M Coyne. (2015) Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis. Clinical Ophthalmology 9, pages 1215-1225.
Read now
Read now
Articles from other publishers (10)
Yumna Zaheer, Thomas Vorup‐Jensen, Thomas J. Webster, Mukhtiar Ahmed, Waheed S. Khan & Ayesha Ihsan. (2021) Protein based nanomedicine: Promising therapeutic modalities against inflammatory disorders. Nano Select 3:4, pages 733-750.
Crossref
Crossref
Yingxin Zi, Yu Deng, Meiqi Ji, Yali Qin, Luqi Nong, Ziqiang Liu & Ming Jin. (2020) The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis. Medicine 99:7, pages e18618.
Crossref
Crossref
DeGaulle I. Chigbu, Pooja Jain & Zafar K. Khan. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control
229
277
.
Claudio Bucolo, Annamaria Fidilio, Claudia Giuseppina Fresta, Francesca Lazzara, Chiara Bianca Maria Platania, Giuseppina Cantarella, Giulia Di Benedetto, Chiara Burgaletto, Renato Bernardini, Cateno Piazza, Stefano Barabino & Filippo Drago. (2019) Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Maria Teresa Ventura, Nicola Scichilone, Roberto Paganelli, Paola Lucia Minciullo, Vincenzo Patella, Matteo Bonini, Giovanni Passalacqua, Carlo Lombardi, Livio Simioni, Erminia Ridolo, Stefano R. Del Giacco, Sebastiano Gangemi & Giorgio Walter Canonica. (2017) Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms. Clinical and Molecular Allergy 15:1.
Crossref
Crossref
Yang Yang, Xiaolong Yin, Jinglin Yi & Xiaowei Peng. (2017) MiR-146a overexpression effectively improves experimental allergic conjunctivitis through regulating CD4+CD25−T cells. Biomedicine & Pharmacotherapy 94, pages 937-943.
Crossref
Crossref
Hyungbin Hwang. (2017) Pathogenesis of allergic conjunctivitis and trends in its treatment. Journal of the Korean Medical Association 60:3, pages 251.
Crossref
Crossref
Anca Maria Cimpean & Marius Raica. (2016) The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent. Archivum Immunologiae et Therapiae Experimentalis 64:6, pages 515-522.
Crossref
Crossref
Pavol Surda & Wytske J. Fokkens. (2016) Novel, Alternative, and Controversial Therapies of Rhinitis. Immunology and Allergy Clinics of North America 36:2, pages 401-423.
Crossref
Crossref
Eugene McLaurin, Abhijit Narvekar, Paul Gomes, Adeniyi Adewale & Gail Torkildsen. (2015) Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model. Cornea 34:10, pages 1245-1251.
Crossref
Crossref